1-3 of 3
Sarah Gooding, MD
Close
Sort by
Journal Articles

Clinical-Grade Whole Genome Sequencing Reproduces FISH Cytogenetics and Provides Actionable Data in Newly Diagnosed Myeloma - a Pilot Study from the UK 100,000 Genomes Project

Oliver Lomas, MD DPhil, MRCP, Sarah Gooding, MD PhD, Karthik Ramasamy, MD PhD, Angela Hamblin, MD PhD, Maite Cabes, PhD, Helene Marie-Pierre Dreau, PhD, Edward Wilson, FRCPath, MRCP
Journal: Blood
Blood (2019) 134 (Supplement_1): 3062.
https://doi.org/10.1182/blood-2019-125145
Published: 2019
Journal Articles

Large-Scale Analysis of Relapsed/Refractory Multiple Myeloma Genome Reveals Increased Prevalence of High-Risk Molecular Features and Oncogenic Drivers

Fadi Towfic, PhD, Naser Ansari-Pour, PhD, Maria Ortiz, Sarah Gooding, MD PhD, Dan Rozelle, PhD, Victoria Zadorozhny, Konstantinos Mavrommatis, PhD, Sneh Lata, PhD, Nicholas Stong, PhD, Sitharthan Kamalakaran, PhD, Kao-Tai Tsai, Erin Flynt, Anjan Thakurta
Journal: Blood
Blood (2019) 134 (Supplement_1): 365.
https://doi.org/10.1182/blood-2019-124939
Published: 2019
Journal Articles

Transcriptome Profiling of the Myeloma-Bone Niche Identifies BMP Signaling Role in Bone Destruction and Niche Maintenance, and Potential As a Therapeutic Target

Sarah Gooding, MD, Siobhan Webb, PhD, Sam Olechnowicz, PhD, Seint Lwin, PhD, Andrew Armitage, PhD, Karthik Ramasamy, Claire M. Edwards, PhD, Alexander Drakesmith, PhD
Journal: Blood
Blood (2016) 128 (22): 483.
https://doi.org/10.1182/blood.V128.22.483.483
Published: 2016